| |
|
|
|
scPharmaceuticals Inc.  
|
|
2.95 -0.18 (-0.06%) |
03-22 16:00 |
|
Open: |
3.13 |
Pre close: |
3.13 |
Target:
|
3.76 
|
|
High: |
3.365 |
Low: |
2.95 |
Resistance:
|
3.22
3.50
|
|
Volume: |
13,212 |
Market Cap: |
55M |
Support:
|
2.76
2.30
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.10
|
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
3.23 |
Signal(12,26,9): |
-0.09 |
|
MA(100): |
3.96 |
Stochastic Oscillator |
%K(14,3):
|
7.63 |
|
MA(250): |
6.07 |
%D(3): |
13.35 |
|
Average Volume(K) |
3-Month: |
3080
|
52-Week |
High:
|
15.70 |
|
10-Days: |
1475 |
Low: |
2.76 |
|
RSI |
RSI(14):
|
36.79 |
Change(%): |
-76.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.110 |
Return on Equity (ttm) |
-60.6 |
Shares Out. (M) |
18.57 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-47.0 |
Shares Float (M) |
18.48 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.50 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
46.30 |
|
Forward EPS |
-2.159 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.760 |
EBITDA (p.s.) |
0.000 |
P/E |
-1.40 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.88 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-28.95 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-18.53 |
P/CF |
-1.89 |
|
|
|
|
|
|
